Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Watson

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|May 5, 2007
Sequential adhesion of platelets and leukocytes from flowing whole blood onto a collagen-coated surface: requirement for a GpVI-binding site in collagenLynn M Butler, Tom Metson-Scott, Jo Felix, et al.
Platelets|September 28, 2020
Loss of mDia1 and Fhod1 impacts platelet formation but not platelet functionMalou Zuidscherwoude, Elizabeth J Haining, Victoria A Simms, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
The identification of novel acid isostere based inhibitors of the VPS10P family sorting receptor SortilinJacob Lauwring Andersen, Samsa Lindberg, Morten Langgård, et al.
Platelets|April 17, 2026
Nanobodies to GPVI as alternative reagents for platelet spreadingAlexandre Slater, Hsin-Yun Pan, Tz-Han Ho, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2025
Expansion microscopy allows quantitative characterization of structural organization of platelet aggregatesEmma L Faulkner, Jeremy A Pike, Evelyn Garlick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 14, 2025
Preclinical pharmacokinetics, metabolism, and disposition of NXE0041178, a novel orally bioavailable agonist of the GPR52 receptor with potential for treatment of schizophrenia and related psychiatric disordersSimon Poulter, Nigel Austin, Stephen P Watson, et al.
Blood|March 29, 2012
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopeniaBruce S Sachais, Ann H Rux, Douglas B Cines, et al.
The Journal of Experimental Medicine|March 20, 2002
Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signalingBarbi A Judd, Peggy S Myung, Achim Obergfell, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2021
Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?Walid Chayoua, Phillip L R Nicolson, Joost C M Meijers, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric DisordersSimon Poulter, Nigel Austin, Rachel Armstrong, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|May 5, 2007
Sequential adhesion of platelets and leukocytes from flowing whole blood onto a collagen-coated surface: requirement for a GpVI-binding site in collagenLynn M Butler, Tom Metson-Scott, Jo Felix, et al.
Platelets|September 28, 2020
Loss of mDia1 and Fhod1 impacts platelet formation but not platelet functionMalou Zuidscherwoude, Elizabeth J Haining, Victoria A Simms, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
The identification of novel acid isostere based inhibitors of the VPS10P family sorting receptor SortilinJacob Lauwring Andersen, Samsa Lindberg, Morten Langgård, et al.
Platelets|April 17, 2026
Nanobodies to GPVI as alternative reagents for platelet spreadingAlexandre Slater, Hsin-Yun Pan, Tz-Han Ho, et al.
Journal of Thrombosis and Haemostasis : JTH|April 27, 2025
Expansion microscopy allows quantitative characterization of structural organization of platelet aggregatesEmma L Faulkner, Jeremy A Pike, Evelyn Garlick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 14, 2025
Preclinical pharmacokinetics, metabolism, and disposition of NXE0041178, a novel orally bioavailable agonist of the GPR52 receptor with potential for treatment of schizophrenia and related psychiatric disordersSimon Poulter, Nigel Austin, Stephen P Watson, et al.
Blood|March 29, 2012
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopeniaBruce S Sachais, Ann H Rux, Douglas B Cines, et al.
The Journal of Experimental Medicine|March 20, 2002
Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signalingBarbi A Judd, Peggy S Myung, Achim Obergfell, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2021
Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?Walid Chayoua, Phillip L R Nicolson, Joost C M Meijers, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric DisordersSimon Poulter, Nigel Austin, Rachel Armstrong, et al.
Pageof 5